Digital health startup iLoF secures €4.89 million to accelerate personalised drug discovery

Published on July 28, 2022

Based between Oxford and Lisbon, iLoF is a biotech startup on a mission to make a difference in the world. The company is developing a platform that creates improved access to personalised medicine for the millions of people around the world living with complex diseases. The development of medicines and treatments has generally been done…

This content is for members only. Visit the site and log in/register to read.

The post Digital health startup iLoF secures €4.89 million to accelerate personalised drug discovery appeared first on EU-Startups.

Continue reading on website
Other news

Can These Two Airline Stocks Overcome Gravity And Fly Higher?

July 28, 2022
Airlines as a group are hardly flying high, but American Airlines (NASDAQ: AAL) and Delta Air Lines (NYSE: DAL) are participating in this week’s market rally.

Bristol-based Condense lands €4.4 million to bring live events into the metaverse

July 28, 2022
Bristol-based startup Condense is on a mission to deliver the authenticity and connectivity of real-world events into the metaverse. The young team has just picked up €4.4 million and has opened a world-first metaverse studio. The metaverse boom has brought about lots of fresh innovation and futuristic technology. Bringing the real world into the digital… This content is for members only. Visit th